Arrowhead Research | Ordinære Aksjekapital



Ordinary Share Capital Endring Dato
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Arrowhead Research USD 218K 1000 2024-12
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Ligand Pharmaceuticals USD 20K 1000 2024-12
Merck USD 1.79B 0 2024-12
Moderna USD 38.7K 100 2025-03
Novartis USD 793M 0 2024-12
Sarepta Therapeutics USD 10K 0 2024-12
TG Therapeutics USD 156K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Xencor USD 703K 2K 2024-12



Arrowhead Research Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.